No Detail Found!

Update to south Asian consensus guideline: Use of newer insulins in diabetes during Ramadan.

Author(s)
Faruque Pathan Department of Endocrinology, Osmania Medical College, Hyderabad, India
Zafar Ahmed Latif BIRDEM, Dhaka, Bangladesh
Rakesh Kumar Sahay Department of Endocrinology, Osmania Medical College, Hyderabad, India
Abdul Hamid Zargar Department of Endocrinology, Advanced Center for Diabetes and Endocrine Care, Srinagar, India
Syed Abbas Raza Department of Endocrinology, Shaukhat Khanum Cancer Hospital and Research Center, Lahore, Pakistan
Ak Azad Khan Diabetic Association of Bangladesh, Bangladesh
Nazrul Islam Siddiqui Department of Endocrinology, Mymensingh Medical College, Mymensingh, Bangladesh
Feroz Amin Department of Endocrinology, Osmania Medical College, Hyderabad, India
Osama Ishtiaq Department of Endocrinology, Shifa International Hospital, Islamabad, Pakistan
Dina Shrestha Endocrinology, Shifa International Hospital, Islamabad, Pakistan; Department of Endocrinology, Norvic International Hospital, Kathmandu, Nepal
Noel Somasundaram Diabetes and Endocrine Unit, National Hospital, Colombo, Sri Lanka
Sanjay Kalra Department of Endocrinology, Bharti Hospital, Karnal, india
Abstract
This guidance is an update to the South Asian Consensus Guideline: Use of Insulin in Diabetes during Ramadan, published in the Indian Journal of Endocrinology and Metabolism in 2012. A five country working group has collated evidence and experience to suggest guidelines for the safe and rational use of insulin degludec (IDeg) and insulin degludec aspart (IDegAsp) during Ramadan. The suggestions contained herewith are based on the pharmacokinetic and pharmacodynamics properties of these novel insulins.
Publication Details
Page(s) 777-778
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 66, Issue: 6, Year: 2016

Request the full text from PASTIC

0

Citations

0

Downloads

136

Views